XML 66 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share Capital (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Share Capital [Abstract]      
Schedule of Shares Issued and Outstanding

Cost:

 

Number of shares

 

Capital

Balance, December 31, 2021

 

2,223,131

 

 

$

7,255,695

 

Issuance of shares to ASDT

 

86,996

 

 

 

2,124,615

 

Issuance of shares from private placement

 

16,200

 

 

 

278,481

 

Issuance of shares upon conversion of note

 

164,574

 

 

 

6,559,000

 

Issuance of shares from IPO

 

400,000

 

 

 

14,654,593

 

Issuance of shares in Holigen acquisition (note 4)

 

190,000

 

 

 

16,131,000

 

Loss of control of Bophelo Bio

 

 

 

 

(156

)

Fair value of RSUs issued at $9.70 per share

 

112,456

 

 

 

1,090,832

 

Fair value of RSUs issued at $8.29 per share

 

67,567

 

 

 

560,135

 

Fair value of RSUs issued at $7.10 per share

 

60,810

 

 

 

431,757

 

Fair value of RSUs issued at $2.57 per share

 

82,000

 

 

 

210,740

 

Fair value of RSUs issued at $2.30 per share

 

60,000

 

 

 

138,000

 

Balance, December 31, 2022

 

3,463,734

 

 

 

49,434,692

 

Fair value of RSUs issued at $1.84 per share

 

421,052

 

 

 

774,736

 

Fair value of RSUs issued at $1.11 per share

 

161,295

 

 

 

179,037

 

Cancelled shares

 

(20,620

)

 

 

(200,014

)

Balance, June 30, 2023

 

4,025,461

 

 

$

50,188,451

 

Cost:

 

Number of 
shares

 

Capital

Balance, December 31, 2020

 

13,129,212

 

$

1,636

 

Shares issued to founders

 

5,626,806

 

 

1

 

Seed subscription

 

468,900

 

 

250,000

 

Private Placement

 

2,126,400

 

 

4,804,058

 

Settlement of Bridge Loan

 

880,000

 

 

2,200,000

 

Balance, December 31, 2021

 

22,231,318

 

$

7,255,695

 

Issuance of shares to ASDT

 

869,963

 

 

2,124,615

 

Issuance of shares from private placement

 

162,000

 

 

278,481

 

Issuance of shares upon conversion of note

 

1,645,745

 

 

6,559,000

 

Issuance of shares from IPO

 

4,000,000

 

 

14,654,593

 

Issuance of shares in Holigen acquisition (note 4)

 

1,900,000

 

 

16,131,000

 

Loss of control of Bophelo Bio

 

 

 

(156

)

Fair value of RSU’s issued at $0.97 per share

 

1,124,569

 

 

1,090,832

 

Fair value of RSU’s issued at $0.83 per share

 

675,676

 

 

560,135

 

Fair value of RSU’s issued at $0.71 per share

 

608,108

 

 

431,757

 

Fair value of RSU’s issued at $0.26 per share

 

820,000

 

 

210,740

 

Fair value of RSU’s issued at $0.23 per share

 

600,000

 

 

138,000

 

Balance, December 31, 2022

 

34,637,379

 

$

49,434,692

 

Shares issued and outstanding are as follows:

Cost:

 

Number of 
shares

 

Capital

Balance, December 31, 2019

 

13,129,212

 

$

1,636

Balance, December 31, 2020

 

13,129,212

 

 

1,636

Shares issued to founders

 

5,626,806

 

 

1

Seed subscription

 

468,900

 

 

250,000

Private Placement

 

2,126,400

 

 

4,804,058

Settlement of Bridge Loan

 

880,000

 

 

2,200,000

Balance, December 31, 2021

 

22,231,318

 

$

7,255,695

Schedule of Outstanding RSUs A summary of the Company’s outstanding RSUs as at June 30, 2023 are as follows:
 

Number of
RSUs

Balance, December 31, 2021

 

 

Granted

 

780,400

 

Exercised

 

(382,835

)

Balance, December 31, 2022

 

397,565

 

Granted

 

1,058,306

 

Cancelled

 

(475,959

)

Exercised

 

(582,347

)

Balance, June 30, 2023

 

397,565

 

A summary of the Company’s outstanding RSUs as at December 31, 2022 are as follows:
 

Number of RSUs

Balance, December 31, 2021

 

 

Granted

 

7,804,046

 

Exercised

 

(3,828,353

)

Balance, December 31, 2022

 

3,975,693